Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Lascorz, Jesus ^a   Bevier, Melanie ^a   Schönfels, Witigo V ^b   Kalthoff, Holger ^b   Aselmann, Heiko ^b   Beckmann, Jan ^b   Egberts, Jan ^b   Buch, Stephan ^b   Becker, Thomas ^b   Schreiber, Stefan ^b   Hampe, Jochen ^b   Hemminki, Kari ^a,c   Försti, Asta ^a,c   Schafmayer, Clemens ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER PATIENT; CLINICAL EVALUATION; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GERMANY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; OXIDATIVE PHOSPHORYLATION; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; CANCER STAGING; COHORT ANALYSIS; COLORECTAL TUMOR; GENETICS; GENOTYPE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MITOCHONDRION; MORTALITY; RISK;

CARRIER PROTEIN; COX6B1 PROTEIN, HUMAN; CYTOCHROME C OXIDASE; TUMOR MARKER; UBIQUINONE BINDING PROTEINS; UBIQUINONE-BINDING PROTEINS;

3' UNTRANSLATED REGIONS; AGED; ALLELES; CARRIER PROTEINS; COHORT STUDIES; COLORECTAL NEOPLASMS; ELECTRON TRANSPORT COMPLEX IV; FEMALE; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOCHONDRIA; NEOPLASM STAGING; ODDS RATIO; OXIDATIVE PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862232907     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-31     Document Type: Article

References (23)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917. 10.1002/ijc.25516, 21351269.
2. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009, 9(7):489-499. 10.1038/nrc2645, 19536109.
3. Lascorz J, Chen B, Hemminki K, Forsti A. Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies. PLoS One 2011, 6(4):e18867. 10.1371/journal.pone.0018867, 3081819, 21541025.
4. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124(3215):269-270.
5. Levine AJ, Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010, 330(6009):1340-1344. 10.1126/science.1193494, 21127244.
6. Cuezva JM, Sanchez-Arago M, Sala S, Blanco-Rivero A, Ortega AD. A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer. J Bioenerg Biomembr 2007, 39(3):259-265. 10.1007/s10863-007-9087-9, 17712532.
7. Ristow M. Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care 2006, 9(4):339-345. 10.1097/01.mco.0000232892.43921.98, 16778561.
8. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011, 11(5):325-337. 10.1038/nrc3038, 21508971.
9. Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 2003, 3(3):193-202. 10.1038/nrc1013, 12612654.
10. Chandra D, Singh KK. Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta 2010, 1807(6):620-625.
11. Krawczak M, Nikolaus S, von Eberstein H, Croucher PJ, El Mokhtari NE, Schreiber S. PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet 2006, 9(1):55-61. 10.1159/000090694, 16490960.
12. Castro FA, Forsti A, Buch S, Kalthoff H, Krauss C, Bauer M, Egberts J, Schniewind B, Broering DC, Schreiber S, et al. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer 2011, 47(8):1203-1210. 10.1016/j.ejca.2010.12.011, 21239167.
13. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:D277-D280. (Database issue), 10.1093/nar/gkh063, 308797, 14681412.
14. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265. 10.1093/bioinformatics/bth457, 15297300.
15. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, Wong KC, Taylor J, Burnett E, Gut I, Farrall M, et al. A genome-wide association study of global gene expression. Nat Genet 2007, 39(10):1202-1207. 10.1038/ng2109, 17873877.
16. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249. 10.1038/nmeth0410-248, 2855889, 20354512.
17. Hemminki K, Chen B. Familial risks for colorectal cancer show evidence on recessive inheritance. Int J Cancer 2005, 115(5):835-838. 10.1002/ijc.20938, 15704173.
18. Storm HH, Engholm G, Hakulinen T, Tryggvadottir L, Klint A, Gislum M, Kejs AM, Bray F. Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol 2010, 49(5):532-544. 10.3109/02841861003801148, 20491522.
19. Harada T, Chelala C, Crnogorac-Jurcevic T, Lemoine NR. Genome-wide analysis of pancreatic cancer using microarray-based techniques. Pancreatology 2009, 9(1-2):13-24.
20. Jung HJ, Shim JS, Lee J, Song YM, Park KC, Choi SH, Kim ND, Yoon JH, Mungai PT, Schumacker PT, et al. Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing. J Biol Chem 2010, 285(15):11584-11595. 10.1074/jbc.M109.087809, 2857036, 20145250.
21. Massa V, Fernandez-Vizarra E, Alshahwan S, Bakhsh E, Goffrini P, Ferrero I, Mereghetti P, D'Adamo P, Gasparini P, Zeviani M. Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am J Hum Genet 2008, 82(6):1281-1289. 10.1016/j.ajhg.2008.05.002, 2427282, 18499082.
22. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, Schaid DJ, Thibodeau SN. Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008, 17(12):3558-3566. 10.1158/1055-9965.EPI-08-0434, 2750891, 19064571.
23. Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, et al. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2011, 20(6):1131-1145. 10.1158/1055-9965.EPI-10-1224, 3111851, 21447778.